コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 logical disorders, metabolic abnormality and premature death.
2 ibrosis, apoptosis, cardiac dysfunction, and premature death.
3 nsistently associated with increased risk of premature death.
4 ibrosis, apoptosis, cardiac dysfunction, and premature death.
5 behavioral abnormalities, and prevention of premature death.
6 lead to a considerable change in the risk of premature death.
7 late-onset lymphoid cancer development, and premature death.
8 l lung disease, ulcerative skin lesions, and premature death.
9 ss to fibrosis and cirrhosis contributing to premature death.
10 nd adults and that, if untreated, results in premature death.
11 with no indications of cardiac pathology or premature death.
12 pread central nervous system dysfunction and premature death.
13 heart failure, reduced quality of life, and premature death.
14 ical degeneration that causes disability and premature death.
15 often results in advanced heart failure and premature death.
16 mia, T cell cytopenia, skin ulcerations, and premature death.
17 r risk factor for stroke, heart failure, and premature death.
18 quently culminate in right heart failure and premature death.
19 n leading to abnormal foetal development and premature death.
20 ociated with cardiovascular disease risk and premature death.
21 r risk factor for cardiovascular disease and premature death.
22 ations, severe cardiovascular pathology, and premature death.
23 progressive cognitive and motor decline, and premature death.
24 ing disease leading to severe disability and premature death.
25 sis that increase the risk of arrhythmia and premature death.
26 use progressive neurologic deterioration and premature death.
27 d cardiac ventricular hypertrophy leading to premature death.
28 e motor neuron loss leading to paralysis and premature death.
29 factor for ESRD, cardiovascular disease, and premature death.
30 istance, right ventricular (RV) failure, and premature death.
31 pread sickling and tissue damage, leading to premature death.
32 e dementia, movement disorders, seizures and premature death.
33 idney failure, cardiovascular morbidity, and premature death.
34 pathy that leads to hind limb spasticity and premature death.
35 n of morbidity and are at increased risk for premature death.
36 cardiomyopathy, myocardial infarctions, and premature death.
37 hy (DCM), a major cause of heart failure and premature death.
38 factor for cardiovascular disease (CVD) and premature death.
39 ve stress, symptoms of hemolytic anemia, and premature death.
40 , blindness, motor and cognitive decline and premature death.
41 a strong predictor of subsequent suicide and premature death.
42 tios for cardiomyopathy by family history of premature death.
43 hich can progress to heart failure and cause premature death.
44 ion, Purkinje cell death, lipid storage, and premature death.
45 emodelling, progression to heart failure and premature death.
46 l infarction, heart failure, and stroke, and premature death.
47 ncluding severe neurological impairments and premature death.
48 an adults have extraordinarily high rates of premature death.
49 n, impairment of mobility, and in some cases premature death.
50 Rap1b induced massive glomerulosclerosis and premature death.
51 vors (CCSs) are at high risk for illness and premature death.
52 t lead to muscle wasting and, in most cases, premature death.
53 en living in adverse contexts are at risk of premature death.
54 g neuropathy, failed muscle regeneration and premature death.
55 ized by progressive neuronal dysfunction and premature death.
56 s to loss of abdominal fat, infertility, and premature death.
57 ing,respiratory and cardiac impairments, and premature death.
58 rs may have greater risk for poor health and premature death.
59 s in neurons, severe locomotion defects, and premature death.
60 are generalized skeletal muscle weakness and premature death.
61 rupted skin and hair development, and caused premature death.
62 , blindness, motor and cognitive decline and premature death.
63 heart failure, reduced quality of life, and premature death.
64 e phenotype with impaired liver function and premature death.
65 is and fibrosis, dilated cardiomyopathy, and premature death.
66 tributed to myocyte loss, heart failure, and premature death.
67 O2 suggest that traffic pollution relates to premature death.
68 malities, compromised motor performance, and premature death.
69 eta and hs-CRP concentrations on the risk of premature death.
70 , motor and cognitive decline, seizures, and premature death.
71 antibiotic exposure may be a risk factor of premature death.
72 rated macrocephaly, spontaneous seizures and premature death.
73 a wheelchair, respiratory insufficiency and premature death.
74 ge to skeletal and cardiac muscle leading to premature death.
75 lications that collectively increase risk of premature death.
76 s that contribute to increased morbidity and premature death.
77 alters organ-to-body proportions, and causes premature death.
78 s, cognitive and motor decline, seizures and premature death.
79 t with neurodegeneration, loss of vision and premature death.
80 motor and respiratory deficits, seizures and premature death.
81 ult in accelerated lung function decline and premature death.
82 rder (OUD) is associated with a high risk of premature death.
83 hy associated with diastolic dysfunction and premature death.
84 progressive muscle wasting and weakness and premature death.
85 tive impairment, autistic-like behavior, and premature death.
86 Heart failure is a major cause for premature death.
87 e and progressive course that often leads to premature death.
88 n of advanced disease rather than a cause of premature death.
89 ced ejection fraction, cardiac fibrosis, and premature death.
90 exceptional arterial and organ fragility and premature death.
91 PUFA intake in lowering the risk of CVD and premature death.
92 iseases causing irreversible lung damage and premature death.
93 hepatic steatosis, cardiac hypertrophy, and premature death.
94 nal shortening, hypertrophy, dilatation, and premature death.
95 e to lupus nephritis (LN) have high rates of premature death.
96 cerbated organ damage, ultimately leading to premature deaths.
97 It leads to millions of premature deaths.
98 c health response is needed to avert further premature deaths.
99 global population, cause 3.9 million annual premature deaths.
100 2.5) is a causal factor in over 5% of global premature deaths.
101 in treatment, monitor DST results, and avoid premature deaths.
103 0.1-1.6 mug/m(3)), avoiding an estimated 290 premature deaths, 180 hospital admissions for respirator
105 ires cause poor air quality and thousands of premature deaths across densely populated regions in Equ
107 c fatty liver disease (NAFLD) contributes to premature death along with obesity, diabetes, and cardio
110 for the prevention of CVD complications and premature deaths among individuals with diabetes mellitu
111 h is needed to help decision makers to avoid premature deaths among patients already in hospitals and
114 ic heart disease (RHD) is a leading cause of premature death and disability in low-income countries;
115 However, the magnitude of excess risk of premature death and incident complications remains incom
116 the impact of tobacco smoking on the risk of premature death and its contribution to the excess morta
118 et syndrome, including spontaneous seizures, premature death and seizures triggered by hyperthermia.
119 th percentile), avoiding between 160 and 390 premature deaths and 460 hospitalizations and emergency
120 ulation) would accrue 81.8% of reductions in premature deaths and 87.1% of gains in terms of quality-
121 to be associated with avoidance of 8 million premature deaths and an estimated extended mean life spa
122 Tobacco taxation reduces smoking-related premature deaths and increases government revenues, but
123 al cost $58.7 billion), averting 4.5 million premature deaths and leading to a gain of 51.5 million h
124 al causes of death, resulting in 5.8 million premature deaths and millions more with disability.
125 and has the potential to avoid a few million premature deaths and related morbidity from CVD at low c
126 spastic paraplegia, developmental delay with premature death, and autism spectrum disorder with intel
127 nts (ie, informal care), lost earnings after premature death, and costs associated with individuals w
128 tulate the DS phenotype, including seizures, premature death, and impaired spatial memory performance
129 rder marked by growth retardation, diabetes, premature death, and severe lymphoid and myeloid hypopla
130 ing scenario costs, avert an additional 4.6% premature deaths, and add an additional 9.6% healthy lif
132 o an estimated 16,889 (3,839-30,663, 95% CI) premature deaths annually combining the effects of NMVOC
133 dmissions from exposure to SO2, and up to 30 premature deaths annually due to ECA emission controls.
134 iencies account for an estimated one million premature deaths annually, and for some nations can redu
138 l combustion is associated with four million premature deaths annually; contributes to forest degrada
144 egy for the poorest populations that targets premature death at younger ages, addresses environmental
145 r quality improvements decreased the risk of premature death attributable to PM2.5 sulfate in NC by a
146 eme Court) could substantially decrease U.S. premature deaths attributable to coal-fired power plant
147 Although studies have provided estimates of premature deaths attributable to either heat or cold in
148 ne across Europe will increase the number of premature deaths attributable to ozone pollution each ye
150 aged 40-74 years, we estimated the number of premature deaths averted for all adults and by gender.
153 ent to induce progressive motor symptoms and premature death, but genetically lacks corticospinal neu
155 spholamban (PLB) triggers cardiomyopathy and premature death by altering regulation of sarco/endoplas
157 this population and may also help to reduce premature death by providing a forum for mutual support
158 n lower-middle-income countries would reduce premature deaths by an estimated 4.2 million per year.
159 s on premature avertable mortality from NCDs-premature deaths caused by NCDs that could be prevented
161 nevitability of death (patients), preventing premature death (clinicians), and ensuring safety (regul
162 ted severe growth retardation, kyphosis, and premature death, closely resembling the phenotype of sys
163 us erythematosus (SLE) have a higher rate of premature death compared to the general population, sugg
164 T2 from the brain, resulting in epilepsy and premature death, confirming the importance of EAAT2 for
168 r National Statistics to study all 2 465 285 premature deaths (defined as those before age 75 years)
169 high-income countries, the biggest cause of premature death, defined as death before 70 years, is sm
170 d's adult population and is a major cause of premature death despite considerable advances in pharmac
171 val motor neuron (SMN) protein that leads to premature death due to loss of motor neurons and muscle
174 , leading to progressive muscle weakness and premature death due to respiratory and/or cardiac compli
176 ombin (Serpinc1) or protein C (Proc) display premature death due to thrombosis-related coagulopathy,
177 ere we show, of the 1.08 (0.74-1.42) million premature deaths due to anthropogenic PM(2.5) exposure i
178 of cause-specific outcomes examined, risk of premature death during the first year after discharge wa
180 primary PM(2.5) emissions led to cross-state premature deaths equal to three times those associated w
183 ies could substantially reduce suffering and premature death from cancer before 2030, with even great
186 th of President Franklin D Roosevelt and his premature death from hypertensive heart disease and stro
189 riated muscle wasting disorder that leads to premature death from respiratory and/or cardiac failure.
190 tion of striated muscle wasting resulting in premature death from respiratory and/or cardiac failure.
192 program was predicted to annually prevent 90 premature deaths from AAA and to gain 577 quality-adjust
193 desh contributes to the largest reduction of premature deaths from ambient air pollution, preventing
194 % in India and Nepal, and result in ~300 000 premature deaths from chronic obstructive pulmonary dise
196 0 (142000-172000) and 182000 (163000-197000) premature deaths from heating and cooking emissions, res
197 culosis, HIV, and malaria deaths; a third of premature deaths from non-communicable diseases (NCDs);
199 d with about 38,000 PM2.5- and ozone-related premature deaths globally in 2015, including about 10 pe
200 ulting in stroke, device-exchange surgery or premature death) has been increasing dramatically, which
201 fuel cookstoves is a leading risk factor for premature death; however, the effect of fuel moisture co
208 ecognized site and mechanism contributing to premature death in individuals with leaky RYR2 mutations
209 e hypothyroidism leads to growth defects and premature death in mice, we assayed for changes in thyro
220 death (SCD) are among the leading causes of premature death in the general population, the origins r
223 ease and stroke remain the leading causes of premature death in the world; however, there is wide reg
224 ancer are important causes of disability and premature death in women, who are the primary cooks and
225 ioxide emissions caused the most cross-state premature deaths in 2005, but by 2018 primary PM(2.5) em
226 opogenic PM(2.5) was responsible for 107,000 premature deaths in 2011, at a cost to society of $886 b
229 000 (306000-370000; 95% confidence interval) premature deaths in China are attributable to residentia
231 ardiomyopathy increased 100-fold; given >/=2 premature deaths in first-degree relatives, the rate inc
234 China in 2007 is linked to more than 64,800 premature deaths in regions other than China, including
235 rosis followed by myocardial infarctions and premature deaths in response to high-fat, high-cholester
236 uding about 10 per cent of all ozone-related premature deaths in the 28 European Union member states.
239 other than China, including more than 3,100 premature deaths in western Europe and the USA; on the o
242 st burden of household air pollution-related premature deaths is in children with pneumonia exposed t
243 2 in adipocytes, mediated by aP2-Cre, led to premature death, lack of white fat, low blood pressure,
246 announced its goal of reducing the number of premature deaths (<70 years) due to noncommunicable chro
247 ubertal nadir androgen condition resulted in premature death, maintenance of androgen levels extended
248 ate identification of people at high risk of premature death may assist in the targeting of preventiv
249 A wide spectrum of CV conditions, including premature death, might develop consecutively or in paral
250 ged 25-49 years, an estimated 111 000 excess premature deaths occurred in white individuals and 6600
254 on inhibited IEC apoptosis and prevented the premature death of mice with IEC-specific RIPK1 knockout
256 ay explores the consequences of the imagined premature death of Oswald Avery, who in 1944 provided ev
259 e-dependent manner and substantially reduced premature deaths of APP/PS1-Tg mice at a dose lowering b
263 matter (PM) pollution is a leading cause of premature death, particularly in those with pre-existing
264 cent confidence interval 1.61-4.81) million premature deaths per year worldwide, predominantly in As
267 sis and vascular calcification that leads to premature death, predominantly of myocardial infarction
269 ion in these mice, consequently leading to a premature death rate of 40% within 2 weeks of treatment,
271 o migration drove 137.1 (95%CI: 93.2, 179.4) premature deaths related to air pollution, with rural-ur
274 extent to which these factors contribute to premature death resulting from CRC nationwide and by sta
277 d Health Organization 25x25 risk factors for premature death, smoking and body mass index (BMI) were
278 ment to slow or halt SCAs (many SCAs lead to premature death), the clinical care of patients with SCA
279 ques but profoundly reduced the incidence of premature deaths, the number of thrombi (7 in 249 plaque
280 odelling, decline of cardiac performance and premature death, thereby limiting the use of betaAR agon
282 ulted in a reduction of risk with respect to premature death to 20.6% compared with the control group
283 ing from progressive infantile paralysis and premature death (type I) to limited motor neuron loss an
284 health target, "Avoid in each country 40% of premature deaths (under-70 deaths that would be seen in
285 e change in the number and economic value of premature deaths using modeled changes in ozone levels r
289 severe developmental defects, cell death and premature death, which correlate with the constitutive a
290 require 2 major advancements: (1) minimizing premature death with a functioning graft in the patients
294 of the ten leading causes of disability and premature death worldwide are psychiatric conditions.
297 olid fuels is associated with over 4 million premature deaths worldwide every year including half a m
300 ion people, causing severe complications and premature death, yet the underlying molecular mechanisms